-

07:57:09 PM

LIVE Real Time NVAX Stock Market News

NVAX - Novavax, Inc.

04/14/21 5:39 PM

Nasdaq : NVAX

Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial called Comparing COVID-19

RHEA-AI

neutral

04/13/21 6:42 PM

Nasdaq : NVAX

Novavax Announces Leadership Updates

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the promotion of Gale E. Smith, Ph.D., to Senior Vice President, Discovery and Pre-Clinical Research and

RHEA-AI

neutral

04/13/21 5:34 PM

Nasdaq : NVAX

Novavax Announces Leadership Updates

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the promotion of Gale E. Smith, Ph.D., to Senior Vice President, Discovery and Pre-Clinical Research and

RHEA-AI

neutral

04/08/21 8:05 AM

Nasdaq : NVAX

Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook

RHEA-AI

neutral

04/05/21 4:05 PM

Nasdaq : NVAX

Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover

Novavax, Inc. (Nasdaq: NVAX), a

RHEA-AI

neutral

04/05/21 8:50 AM

Nasdaq : NVAX

Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Stanley C. Erck, President and Chief Executive Officer, will participate in a panel discussion during the

RHEA-AI

neutral

03/29/21 4:02 PM

Nasdaq : NVAX

GSK to support manufacture of Novavax' COVID-19 vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, GSK and the UK Government Vaccines Taskforce announced that they have reached an agreement in principle to support

RHEA-AI

positive

03/11/21 4:02 PM

Nasdaq : NVAX

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company

RHEA-AI

negative

03/08/21 6:00 PM

Nasdaq : NVAX

Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the H.C. Wainwright Virtual Global Life Sciences

RHEA-AI

neutral

03/01/21 4:02 PM

Nasdaq : NVAX

Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

96% vaccine efficacy against original COVID-19 in UK Phase 3 trial Vaccine cross-protection demonstrated against both variants circulating in the UK and South Africa Full enrollment (~30,000 participants) in PREVENT-19 Phase 3 trial Agreements for ~300 million doses to date Additional 1.1 billion

RHEA-AI

neutral

1 2 3 4 5 6 7 8 Next